Join us at PEGSBoston: May 15-19
Join us in our luncheon presentation and meet with our team at booth #9 in PEGS Boston from May 15-19 ! Learn more about our antibody discovery services and other platforms to help support your research projects. Luncheon Session: Tuesday, May 16th, 12:40 PM Speaker: Dr. Qingcong Lin, CEO, Biocytogen Boston Session Title: RenNano: A […]
Join us at ASGCT2023: May 16-20
May 8, 2023
Join us at booth #574 at American Society of Gene & Cell Therapy Annual Meeting 2023 from May 16-20 in Los Angeles, CA! Learn more about our custom model generation services and pharmacology services to support your therapeutic discovery and preclinical validation. Attend the meeting Talk to us at the booth 574! The American […]
Meet Biocytogen’s Business Development Team at BIO KOREA 2023!
May 8, 2023
Biocytogen’s business development team is pleased to exhibit and host 1-on-1 meetings at BIO KOREA 2023, taking place from May 10-12, 2023 in Seoul, South Korea. Join us at booth C5 to learn more about our 6 proprietary fully human antibody discovery RenMiceTM platforms: monoclonal antibody (RenMabTM), bispecific antibody and bispecific ADC (RenLite®), nanobody (RenNano®), TCR-mimic antibody for intracellular targets […]
Immune system-reconstituted models for immuno-oncology research: Applications of CD34+ humanized B-NDG mice
May 5, 2023
Introduction: Choosing the right humanized model for your study The relative success of immuno-oncology drugs has directed research toward discovering novel targets and therapeutic agents. This has also resulted in heightened demands for the establishment and utilization of relevant, robust animal models for in vivo evaluation of novel preclinical drug candidates. With the shift toward […]
Webinar: Joint, Lung, and Urinary Disease Models Offered at Biocytogen
May 3, 2023
Our webinar “Joint, Lung, and Urinary Disease Models Offered at Biocytogen” was live at 1:00 PM EDT on May 25th, 2023. About the Webinar Inflammatory disease models are important preclinical research tools to study disease pathogenesis and uncover novel treatments. To directly evaluate the efficacy and safety of therapeutic drug candidates targeting these disorders, we can […]
Join us at Immunology 2023: May 11-15
April 26, 2023
Join us at booth #4097 at Immunology 2023 from May 11-15 in Washington. D.C! Learn more about our custom model generation services and other platforms to help support your research projects. Attend the meeting Talk to us at the booth 4097! With major lectures from some of the world’s most prominent immunologists, and podium and […]
Humanized PCSK9 mice as a resource for lipid management studies
April 24, 2023
Introduction: mitigating dyslipidemia to prevent cardiovascular disease Dyslipidemia is a metabolic derangement that clinically presents with abnormal levels of lipids (cholesterol, triglycerides, and/or phospholipids) in the blood. Specifically, the condition is marked by high levels of low-density lipoprotein (LDL) and low levels of high-density lipoprotein (HDL) cholesterol. Of note, high levels of LDL cholesterol are […]
AACR 2023 posters
April 23, 2023
We’re attending AACR 2023, held from April 14-19 in Orlando, Florida! For the latest advances, service offerings, and promotions, register now to visit our team at Booth 723, which will be open from April 16-19. Be sure to also visit our 25 posters, which can now be added to your AACR itinerary. About the meeting […]
2023 Popular Mouse Models and Cell Lines
March 28, 2023
Our advanced genome editing technologies have been leveraged by our own development scientists to create hundreds of animal and cell models used in biomedical research all over the world. 13 years since our founding, Biocytogen’s catalog of off-the-shelf gene-edited animal models, BioMice, now contains more than 450 strains. From knock-outs to humanized knock-ins, our models are […]
8th Annual Innate Killer Summit
March 21, 2023
Join us at the 8th Annual Innate Killer Summit in La Jolla, CA from March 28- 30! Our team of experts will be on site to introduce our humanized and immunodeficient models that are specially designed for the assessment of NK Cell-based immunotherapies. Be sure to stop by and meet us! Attend the meeting Talk […]
